16:00-17:00 CET (Brussels time zone)
The Capital Markets and ESG: Insights from the Biopharma Investor ESG Communications Initiative
By Ms. Myrto Kontaxi (Sustainability & ESG Advisor, Partner of the Biopharma Sustainability Roundtable)
Location: Hybrid
Ms. Myrto Kontaxi
Sustainability and ESG Advisor, Partner of the Biopharma Sustainability Roundtable
– Sustainability, ESG, and Impact in the capital markets universe
– The Biopharma Investor ESG Communications Initiative, a brief overview
– Investor objectives and expectations from business
– Business and investor ESG communications: The role of other capital markets stakeholders (i.e. raters, standard-setters)